Oncompass Medicine | Budapest is a Hungarian medical enterprise specializing in personalized cancer treatment. Their Precision Oncology Program offers a comprehensive range of services to determine the most suitable treatment for each patient. The program utilizes advanced medical software developed by Oncompass to analyze clinical data, molecular diagnostic results, and individual patient needs.

Consultations, both online and in-person, play a crucial role in the program's planning phase. A dedicated Tumor Board consisting of clinical oncologists, genetic counselors, and molecular diagnostic experts collaboratively identifies the required molecular diagnostic tests for each patient. Oncompass also ensures sample logistics and quality checks, followed by a detailed molecular diagnostics process to identify disease-causing gene defects in the tumor.

The results are then interpreted using their AI-based software, which enables precise therapy planning and personalized drug assignment. The Molecular Oncoteam compiles the personalized treatment options, including registered drugs and compounds in clinical trials, for each patient. Oncompass Medicine is committed to providing oncology opinion, support for therapy access, and follow-up care to cancer patients and their treating physicians.

Contact them today and discover their innovative approach to precision oncology